====== 2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312 ====== ==== Mechanism of Action ==== Endogenous estradiol metabolite, weak agonist for estrogen receptor, agonist of GPER1, microtubule destabilizer * **Class / Subclass 1:** Metabolism / Metabolite * **Class / Subclass 2:** Signal Transduction / GPCR Agonist * **Class / Subclass 3:** Cell Cycle / Microtubule Poison ==== Technical Notes ==== * **PubChem Name:** %%2-Methoxyestradiol%% * **Synonyms:** 2-ME2; NSC-659853 * **CAS #:** 362-07-2 * **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/66414|66414]] * **IUPAC:** %%(8R,9S,13S,14S,17S)-2-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol%% * **INCHI Name:** InChI=1S/C19H26O3/c1-19-8-7-12-13(15(19)5-6-18(19)21)4-3-11-9-16(20)17(22-2)10-14(11)12/h9-10,12-13,15,18,20-21H,3-8H2,1-2H3/t12-,13+,15-,18-,19-/m0/s1 * **INCHI Key:** CQOQDQWUFQDJMK-SSTWWWIQSA-N * **Molecular Weight:** 302.4 * **Canonical SMILES:** CC12CCC3C(C1CCC2O)CCC4=CC(=C(C=C34)OC)O * **Isomeric SMILES:** C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=C(C=C34)OC)O * **Molecular Formula:** C19H26O3 {{:chemogenomics:structures:chem-0021.svg?nolink}} * **Supplier Name:** Toronto Research Chemicals * **Catalog #:** M262625 * **Lot #:** 1-GNM-86-4 * **HRMS (ESI-TOF) m/z:** (M+H)+ Calcd for C19H26O3 303.19547; found 303.19491 * **Platform ID:** Methoxy_b-Estradiol * **Min:** -4.8666; **Max:** 98.0088 {{:chemogenomics:dose_response:dr_390.png?nolink&500 |}} \\ \\ \\ \\ |< 300px 100px 200px >| ^ IC ^ Concentration (µM) ^ | IC10 |N/A | | IC20 |0.1847 | | IC30 |0.2756 | | IC40 |0.3897 | | IC50 |0.5415 | | IC60 |N/A | | IC70 |N/A | | IC80 |N/A | | IC90 |N/A | \\ ==== Screen Summary ==== * **Round**: 07 * **Dose**: 0.55-1µM * **Days of incubation**: 8 * **Doublings**: 5.0 * **Numbers of reads**: 16393425 ==== Screen Results ==== ^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^ |4/12|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/2-Methoxyestradiol_0.55-1day4uM_Round-7_exp312.txt|Scores]]|||||| {{:chemogenomics:cranks_plots:exp312.png?nolink}} ^Gene^CRANKS Score^FDR^ |[[:human_genes:P:PDS5B|PDS5B]]|-3.08|<0.01| |[[:human_genes:A:ASPM|ASPM]]|-3.07|0.01| |[[:human_genes:R:RSRC2|RSRC2]]|-3.05|0.15| |[[:human_genes:M:MSI2|MSI2]]|-2.83|0.04| |[[:human_genes:E:ESCO2|ESCO2]]|-2.80|0.02| |[[:human_genes:P:PSMB8|PSMB8]]|-2.58|0.05| |[[:human_genes:C:CALM2|CALM2]]|-2.54|0.08| |[[:human_genes:C:CNOT2|CNOT2]]|-2.51|0.06| |[[:human_genes:R:RBM26|RBM26]]|-2.51|0.08| |[[:human_genes:N:NPRL2|NPRL2]]|-2.45|0.07| |[[:human_genes:D:DDX3X|DDX3X]]|-2.42|0.08| |[[:human_genes:W:WDR26|WDR26]]|-2.40|0.14| |[[:human_genes:K:KIF11|KIF11]]|-2.39|0.56| |[[:human_genes:L:LRRC8A|LRRC8A]]|-2.35|0.08| |[[:human_genes:B:BRD1|BRD1]]|-2.31|0.10| |[[:human_genes:F:FNDC9|FNDC9]]|-2.31|0.13| |[[:human_genes:C:CENPN|CENPN]]|-2.30|0.13| |[[:human_genes:U:UBE2I|UBE2I]]|-2.29|0.13| |[[:human_genes:T:TAOK3|TAOK3]]|-2.27|0.11| |[[:human_genes:Q:QRICH1|QRICH1]]|-2.27|0.20| |[[:human_genes:T:TMC2|TMC2]]|-2.25|0.14| |[[:human_genes:G:GID8|GID8]]|-2.25|0.11| |[[:human_genes:Z:ZWILCH|ZWILCH]]|-2.25|0.11| |[[:human_genes:F:FAM122A|FAM122A]]|-2.24|0.11| |[[:human_genes:Z:ZW10|ZW10]]|-2.20|0.13| |[[:human_genes:S:SSR1|SSR1]]|-2.19|0.13| |[[:human_genes:C:CWC27|CWC27]]|-2.17|0.13| |[[:human_genes:T:TCF4|TCF4]]|-2.13|0.14| |[[:human_genes:K:KIF18A|KIF18A]]|-2.12|0.14| |[[:human_genes:C:CORO6|CORO6]]|-2.11|0.14| |[[:human_genes:P:PTPMT1|PTPMT1]]|2.06|0.34| |[[:human_genes:C:CCNF|CCNF]]|2.06|0.30| |[[:human_genes:T:TNNC1|TNNC1]]|2.09|0.20| |[[:human_genes:L:LARS2|LARS2]]|2.11|0.28| |[[:human_genes:C:CAP2|CAP2]]|2.11|0.28| |[[:human_genes:T:TRIM28|TRIM28]]|2.13|0.17| |[[:human_genes:C:CDC5L|CDC5L]]|2.16|0.38| |[[:human_genes:D:DEFB115|DEFB115]]|2.20|0.21| |[[:human_genes:H:H2AFZ|H2AFZ]]|2.22|0.11| |[[:human_genes:S:SEC14L1|SEC14L1]]|2.23|0.11| |[[:human_genes:I:ING5|ING5]]|2.23|0.11| |[[:human_genes:A:ATAT1|ATAT1]]|2.27|0.09| |[[:human_genes:C:CARD16|CARD16]]|2.29|0.09| |[[:human_genes:C:CLASP2|CLASP2]]|2.29|0.09| |[[:human_genes:C:COPE|COPE]]|2.34|0.57| |[[:human_genes:Z:ZNF592|ZNF592]]|2.34|0.21| |[[:human_genes:D:DYNC1H1|DYNC1H1]]|2.35|0.47| |[[:human_genes:A:ARHGAP11B|ARHGAP11B]]|2.39|0.06| |[[:human_genes:N:NDE1|NDE1]]|2.43|0.05| |[[:human_genes:S:SLC25A51|SLC25A51]]|2.46|0.05| |[[:human_genes:A:AMBRA1|AMBRA1]]|2.46|0.05| |[[:human_genes:T:TP53|TP53]]|2.71|0.04| |[[:human_genes:N:NUMA1|NUMA1]]|2.76|0.03| |[[:human_genes:A:AFF1|AFF1]]|2.77|0.05| |[[:human_genes:K:KIF18B|KIF18B]]|2.89|<0.01| |[[:human_genes:P:PPP2R1A|PPP2R1A]]|3.22|<0.01| |[[:human_genes:A:ATP1A1|ATP1A1]]|3.41|<0.01| |[[:human_genes:S:SETDB1|SETDB1]]|3.48|<0.01| |[[:human_genes:T:TIPRL|TIPRL]]|3.65|<0.01| |[[:human_genes:L:LCMT1|LCMT1]]|5.04|<0.01| ^Screen^Correlation^Plot^ |[[:results:exp460|BML-284 0.09μM R08 exp460]]|0.137|| |[[:results:exp59|UMK57 1μM R01 exp59]]|0.13|| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|0.123|| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|0.121|| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|0.108|| |[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|0.105|| |[[:results:exp517|Quercetin 20μM R08 exp517]]|0.101|| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|0.087|| |[[:results:exp67|BVD-523 15μM R02 exp67]]|0.084|| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|0.084|| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|0.078|| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|0.076|| |[[:results:exp107|UMK57 0.6μM R03 exp107]]|0.067|| |[[:results:exp360|Genistein 15μM R07 exp360]]|0.067|| |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|0.063|| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|0.062|| |[[:results:exp162|BI-D1870 2μM R04 exp162]]|0.06|| |[[:results:exp359|FK-506 30μM R07 exp359]]|0.058|| |[[:results:exp290|LLY-283 2.6μM R06 exp290]]|0.058|| |[[:results:exp502|Milciclib 2μM R08 exp502]]|0.057|| |[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|0.055|| |[[:results:exp128|GSK591 2.6μM R03 exp128]]|0.054|| |[[:results:exp46|HMS-I1 1μM R01 exp46]]|0.053|| |[[:results:exp354|Diepoxybutane 3μM R07 exp354]]|0.052|| |[[:results:exp78|Pterostilbene 16μM R02 exp78]]|0.052|| |[[:results:exp227|Cryptotanshinone 12μM R05 exp227]]|0.051|| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|0.051|| |[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|0.172|| {{:chemogenomics:comparison_plots:exp312_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp312_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp228_vs_exp312.png?nolink |}} {{:chemogenomics:comparison_plots:exp217_vs_exp312.png?nolink |}} {{:chemogenomics:comparison_plots:exp179_vs_exp312.png?nolink |}} {{:chemogenomics:comparison_plots:exp310_vs_exp312.png?nolink |}} {{:chemogenomics:comparison_plots:exp312_vs_exp517.png?nolink |}} {{:chemogenomics:comparison_plots:exp190_vs_exp312.png?nolink |}} {{:chemogenomics:comparison_plots:exp312_vs_exp67.png?nolink |}} {{:chemogenomics:comparison_plots:exp106_vs_exp312.png?nolink |}} {{:chemogenomics:comparison_plots:exp312_vs_exp60.png?nolink |}} {{:chemogenomics:comparison_plots:exp215_vs_exp312.png?nolink |}} {{:chemogenomics:comparison_plots:exp107_vs_exp312.png?nolink |}} {{:chemogenomics:comparison_plots:exp312_vs_exp360.png?nolink |}} {{:chemogenomics:comparison_plots:exp184_vs_exp312.png?nolink |}} {{:chemogenomics:comparison_plots:exp175_vs_exp312.png?nolink |}} {{:chemogenomics:comparison_plots:exp162_vs_exp312.png?nolink |}} {{:chemogenomics:comparison_plots:exp312_vs_exp359.png?nolink |}} {{:chemogenomics:comparison_plots:exp290_vs_exp312.png?nolink |}} {{:chemogenomics:comparison_plots:exp312_vs_exp502.png?nolink |}} {{:chemogenomics:comparison_plots:exp312_vs_exp356.png?nolink |}} {{:chemogenomics:comparison_plots:exp128_vs_exp312.png?nolink |}} {{:chemogenomics:comparison_plots:exp312_vs_exp46.png?nolink |}} {{:chemogenomics:comparison_plots:exp312_vs_exp354.png?nolink |}} {{:chemogenomics:comparison_plots:exp312_vs_exp78.png?nolink |}} {{:chemogenomics:comparison_plots:exp227_vs_exp312.png?nolink |}} {{:chemogenomics:comparison_plots:exp294_vs_exp312.png?nolink |}} {{:chemogenomics:comparison_plots:exp311_vs_exp312.png?nolink |}} ^GO Term^Fold Change^Genes^ |RZZ complex|637.65|ZWILCH,ZW10| |kinetochore microtubule|106.28|ZWILCH,ZW10,KIF18A| |spindle microtubule|41.41|CALM2,KIF11,ZWILCH,ZW10,KIF18A| |chromosome, centromeric region|16.35|PDS5B,ESCO2,CENPN,ZWILCH,ZW10,KIF18A| |chromosome segregation|13.69|ASPM,ESCO2,DDX3X,KIF11,CENPN,ZW10,KIF18A| |chromosomal region|10.28|PDS5B,ESCO2,CENPN,ZWILCH,ZW10,KIF18A| |chromosome organization|10.14|PDS5B,ESCO2,DDX3X,KIF11,CENPN,ZW10,KIF18A| |cell cycle process|8.78|PDS5B,ASPM,ESCO2,CALM2,DDX3X,KIF11,CENPN,UBE2I,TAOK3,ZWILCH,ZW10,KIF18A| |mitotic cell cycle process|8.65|CALM2,KIF11,UBE2I,TAOK3,ZWILCH,ZW10,KIF18A| |mitotic cell cycle|7.44|CALM2,KIF11,UBE2I,TAOK3,ZWILCH,ZW10,KIF18A| ^GO Term^Fold Change^Genes^ |establishment of spindle localization|40.94|NUMA1,NDE1,DYNC1H1,CLASP2| |spindle localization|37.47|NUMA1,NDE1,DYNC1H1,CLASP2| |cytoplasmic microtubule|26.32|KIF18B,NUMA1,DYNC1H1,CLASP2| |mitotic cell cycle process|9.64|LCMT1,PPP2R1A,KIF18B,NUMA1,TP53,NDE1,DYNC1H1,CLASP2,CCNF| |positive regulation of cellular component biogenesis|8.95|SETDB1,NUMA1,TP53,AMBRA1,DYNC1H1,CLASP2,ATAT1,TRIM28| |mitotic cell cycle|8.29|LCMT1,PPP2R1A,KIF18B,NUMA1,TP53,NDE1,DYNC1H1,CLASP2,CCNF| |regulation of cell cycle process|7.19|LCMT1,TIPRL,PPP2R1A,NUMA1,TP53,AMBRA1,DYNC1H1,CDC5L,CCNF| |cell cycle process|5.70|LCMT1,PPP2R1A,KIF18B,NUMA1,TP53,NDE1,DYNC1H1,CLASP2,CCNF|